Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	28.29	-10.42	-14.53
Graham Fair Price	0.40	3.70	3.69
PEG	32.15	-0.70	-1.03
Price/Book	-30.12	1.39	1.99
Price/Cash Flow	28.70	-9.21	-12.91
Prices/Earnings	34.49	-2.42	-3.69
Price/Sales	-37.93	38.11	61.40
Price/FCF	28.70	-9.21	-12.91
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	16.51	-1.34	-1.61
Operating Margin	9.88	-4.23	-4.69
ROA	0.35	-0.08	-0.08
ROE	-0.13	-0.14	-6.67
ROIC	-0.11	-0.11	-0.71
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-80.02
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.02	< 0.005	-55.63
EPS QOQ	-0.04	-0.03	3.45
FCF QOQ	-0.06	0.04	-25.84
Revenue QOQ	0.14	0.10	-29.30
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	152.83	125.76	-17.71
Days Sales Outstanding (DSO)	36.04	72.23	100.44
Inventory Turnover	0.59	0.72	21.52
Debt/Capitalization	0.30	0.31	1.76
Quick Ratio	3.89	3.99	2.45
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.12	2.06	-2.79
Cash	1.68	1.74	3.01
Capex	-0.12	-0.09	27.62
Free Cash Flow	-0.33	-0.31	4.72
Revenue	0.07	0.08	9.45
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.72	4.66	-1.16
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.43	-0.46	67.93
Naive Interpretation	Member

06 - Financial Health · Bad

Rating